Viewing Study NCT05306366


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2025-12-25 @ 3:52 PM
Study NCT ID: NCT05306366
Status: COMPLETED
Last Update Posted: 2022-07-14
First Post: 2022-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants
Sponsor: H. Lundbeck A/S
Organization:

Study Overview

Official Title: Interventional Open-Label Positron Emission Tomography Study Investigating Blood-Brain-Barrier Penetration and Pharmacokinetic Properties of [11C]-Lu AF90103 in Healthy Young Men
Status: COMPLETED
Status Verified Date: 2022-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main goals of the study are to assess uptake and distribution of Lu AF90103 in the brain when given at tracer levels (microdose) in healthy young men.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: